Cardinal Health, Inc.

Cardinal Health, Inc.

CAHยทNYSE

$195.85

+0.50%
HealthcareMedical - Distribution

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

At a Glance

Live Snapshot
Market Cap$45.87B
EPS6.4800
P/E Ratio30.22
Earnings Date08/11/2026
3Y+23.0%
5Y+46.0%
10Y+83.0%
3Y-266.0%
5Y-142.0%
10Y+9.0%
3Y-23.0%
5Y+22.0%
10Y-19.0%
Cardinal Health, Inc.

Cardinal Health, Inc. Profit Bridge

CAH ยท NYSE
Revenue222.58B
Cost of Goods Sold (214.41B)
Gross Profit8.17B
Operating Expenses (5.89B)
Operating Income2.27B
Interest Expense (215.00M)
Other Income/Expense-174.00M
Pretax Income2.10B
Income Tax (532.00M)
Net Income1.56B
Net Income
1.56B

Profitability Analysis

Gross Margin

3.7%

Thin margins leave little room for error. Cost management and pricing strategy are critical.

Operating Margin

1.0%

Minimal operating profit suggests high operating costs or pricing challenges. Scalability is concerning.

Net Profit Margin

0.7%

Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.

Effective Tax Rate

25.3%

Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.

Profitability Insight

Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.

Cardinal Health, Inc. Income Statement

CAH โ€ข NYSE

Cardinal Health, Inc. Income StatementJun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010Jun 2009Jun 2008Jun 2007Jun 2006
REVENUE
222.6B
226.8B
205B
181.3B
162.5B
152.9B
145.5B
136.8B
130B
121.5B
102.5B
91.1B
101.1B
107.6B
102.6B
98.5B
96B
87.4B
86.9B
79.7B
GROSS PROFIT
(214.4B)
(219.4B)
(198.1B)
(174.8B)
(155.7B)
(146.1B)
(138.7B)
(129.6B)
(123.4B)
(115B)
(96.8B)
(85.9B)
(96.2B)
(103B)
(98.5B)
(94.7B)
(92.2B)
(83.6B)
(81.6B)
(74.9B)
8.2B
7.4B
6.9B
6.5B
6.8B
6.9B
6.8B
7.2B
6.5B
6.5B
5.7B
5.2B
4.9B
4.5B
4.2B
3.8B
5.5B
5.6B
5.2B
5.3B
OPERATING INCOME
(5.9B)
(6.2B)
(6.1B)
(7.1B)
(6.3B)
(11B)
(4.8B)
(7.1B)
(4.4B)
(4.1B)
(3.6B)
(3.3B)
(3.9B)
(2.7B)
(2.6B)
(2.5B)
(2.5B)
(2.4B)
(3.9B)
(3B)
(5.4B)
(5B)
(4.8B)
(4.5B)
(4.5B)
(4.6B)
(4.5B)
(4.6B)
(3.8B)
(3.6B)
(3.2B)
(3B)
(2.9B)
(2.7B)
(2.6B)
(2.3B)
(3.4B)
(3.4B)
(3.1B)
(3.2B)
2.3B
1.2B
752M
-607M
472M
-4.1B
2.1B
126M
2.1B
2.5B
2.2B
1.9B
996M
1.8B
1.5B
1.3B
1.3B
1.4B
1.4B
1.8B
PRE-TAX INCOME
(215M)
(51M)
(84M)
(147M)
(180M)
(238M)
(294M)
(329M)
(201M)
(178M)
(141M)
(133M)
(123M)
(95M)
(93M)
(113M)
(218.7M)
(136.1M)
(0.0)
(0.0)
-215M
-51M
-84M
-147M
-180M
-238M
-294M
-329M
-201M
-178M
-141M
-133M
-123M
-95M
-93M
-113M
-114.4M
-136.1M
0.0
0.0
(511M)
(1.2B)
(1.3B)
(2.6B)
(1.8B)
(6.4B)
(294M)
(2.5B)
(649M)
(436M)
(311M)
(248M)
(1.1B)
(72M)
(120M)
(77M)
(126.6M)
(44.1M)
(789.3M)
(86.3M)
-174M
-42M
-89M
-177M
-149M
326M
-309M
-354M
-196M
-183M
-194M
-87M
-108M
-94M
4M
-95M
-127.6M
-97.3M
-121.4M
-104.5M
2.1B
1.2B
663M
-784M
323M
-3.8B
1.8B
-228M
1.9B
2.3B
2B
1.8B
888M
1.7B
1.5B
1.2B
1.7B
1.9B
1.3B
1.8B
NET INCOME
(532M)
(348M)
(332M)
(153M)
-289M
-79M
(386M)
-487M
(630M)
(845M)
(755M)
(635M)
(553M)
(628M)
(552.1M)
(624.6M)
(524.2M)
(633.9M)
(412.6M)
(577.1M)
1.6B
852M
330M
-938M
611M
-3.7B
1.4B
256M
1.3B
1.4B
1.2B
1.2B
334M
1.1B
959M
642.2M
1.2B
1.3B
1.9B
1B

SEC Filings

CAH - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-Q

10-Q 2026 Q1

Q1

April 30, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

April 30, 2026
April 30, 2026
2026
8-K

8-K 2026

N/A

March 23, 2026
March 17, 2026
2026
8-K

8-K 2026

N/A

March 05, 2026
March 02, 2026
2026
10-Q

10-Q 2025 Q4

Q4

February 05, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 05, 2026
February 05, 2026
2026
8-K

8-K 2026

N/A

January 13, 2026
January 13, 2026
2026
8-K

8-K 2025

N/A

November 06, 2025
November 05, 2025
2025
10-Q

10-Q 2025 Q3

Q3

October 30, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

October 30, 2025
October 30, 2025
2025
Showing 1 to 10 of 570 filings